MYEF2 and hepatocellular carcinoma: The expression of MYEF2 was significantly associated with the prognosis of HCC patients, and the prognosis of patients with high expression of MYEF2 was significantly poor, suggesting that MYEF2 might be a prognostic biomarker for HCC.